You are viewing the public part of the archive. Login or request access to view more content.

Type 2 or more characters for results.
Displaying 1-7 of 7 results
first frame of video
00:14:51

2014_09

An interview with Brendan Crabb, President of Burnet Institute, on funding, the role of philanthropy, science today and in the future.

2014_09

first frame of video
00:44:42

2003_7_02

Sten Vermund from University of Alabama reflects on the history of the global AIDS epidemic and his involvement in the field as a young scientist in the 80's. He discusses the social and economic factors of HIV/AIDS, such as stigma, poverty and the drug industry.

2003_7_02

first frame of video
00:11:57

2003_11_03

Interview with George Louis, Professor and Director at the division of Vaccine and Research at the Initiative of Human Virology (IHV) in Baltimore. He talks about the current HIV vaccine trials and reflects on the future.

2003_11_03

first frame of video
00:39:38

2002_1

Opening of the Cent Gardes Conference in Annecy in 2002. Speeches by the Director of Fondation Mérieux, Alain Mérieux, and participants from other institutions working on HIV vaccines. The film maker Staffan Hildebrand holds a speech about Face of AIDS.

2002_1

first frame of video
00:12:54

1994_2 (excerpt)

Joep Lange discusses his views on antiretroviral drugs, both in the developing and the developed world, future improvements of HIV drugs and treatment, and a possible vaccine.

1994_2_edited

first frame of video
00:11:05

1992_6

Geoffrey Schild, Virologist and Director of the National Institute for Biological Standards and Control (NIBSC), talks about the Swedish contributions to AIDS research and collaboration with funding agencies such as Nutek, and reflects on HIV vaccines.

1992_6

first frame of video
00:07:41

1992_5

Dr George Galasso is working on HIV vaccines at NIAID. Here he talks about the scientific challenges of HIV/AIDS and the chances of developing a vaccine. He believes that one of the main focuses in HIV/AIDS research still is to find treatment for opportunistic infections.

1992_5